Abstract
The introduction of induction chemotherapy in the treatment of locally advanced head and neck cancer with protocols based on Cisplatin has increased the number of patients in which complete control of the disease can be attained [1].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bernal AG, Cruz JJ, Sanchez P et al (1989) Four-day continuous infusion of Cis-platinum and 5-Fluorouracil in head and neck cancer. Cancer 63: 1927–1930
Weaver A, Fleming S, Kish J et al (1982) Cisplatinum and 5-Fluorouracil as induction therapy for advanced head and neck cancer. Am J Surg 144: 445–448
Forastiere AA, Belliveau JF, Goren MP et al (1988) Pharmacokinetic and toxicity evaluation of five day continuous infusion versus intermittent bolus of cisdiaminedichloroplatinum ( II) in head and neck cancer patients. Cancer Res 48: 3869–3874
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag France
About this paper
Cite this paper
Fonseca, E. et al. (1991). Neo-Adjuvant chemotherapy with Cisplatin and 5-Fluorouracil, both in continuous 96 hours perfusion, in the multidisciplinary treatment of locally advanced head and neck cancer. In: Banzet, P., Holland, J.F., Khayat, D., Weil, M. (eds) Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy. Springer, Paris. https://doi.org/10.1007/978-2-8178-0782-9_8
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0782-9_8
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0784-3
Online ISBN: 978-2-8178-0782-9
eBook Packages: Springer Book Archive